Testicular relapse in children with acute nonlymphoblastic leukemia

The clinical course and other distinctive features of five children who developed a testicular relapse 4 months to 25 months after the diagnosis of acute nonlymphoblastic leukemia (ANLL) are described. the chief presenting feature at relapse was painless testicular enlargement, as is also seen in ch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 1990-11, Vol.66 (10), p.2095-2098
Hauptverfasser: Furman, Wayne L., Fontanesi, James, Hustu, Omar, Dahl, Gary V., Kalwinsky, David K., Pui, Ching‐Hon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2098
container_issue 10
container_start_page 2095
container_title Cancer
container_volume 66
creator Furman, Wayne L.
Fontanesi, James
Hustu, Omar
Dahl, Gary V.
Kalwinsky, David K.
Pui, Ching‐Hon
description The clinical course and other distinctive features of five children who developed a testicular relapse 4 months to 25 months after the diagnosis of acute nonlymphoblastic leukemia (ANLL) are described. the chief presenting feature at relapse was painless testicular enlargement, as is also seen in children with acute lymphoblastic leukemia who relapse in the testes. By French–American–British convention, the malignant cells were classified as M4 (myelomonoblastic) in four cases and M2 (myeloblastic) in one. All children received a course of multiagent reinduction chemotherapy and all but one received local irradiation to the testes. Only one of these children, whose relapse was a late event after elective cessation of therapy, is a long‐term survivor. A comparison with six previously published cases shows similar clinical characteristics and outcome. Given the poor responses of such patients to conventional treatment, it seems worthwhile to consider the use of intensive reinduction chemotherapy with concomitant bilateral testicular irradiation followed by remission intensification and an autologous or allogenic marrow transplant.
doi_str_mv 10.1002/1097-0142(19901115)66:10<2095::AID-CNCR2820661009>3.0.CO;2-Q
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80069584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80069584</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3879-a0d82a5c0594ece8f843ca6d46b1a80063b6c9dc7e386d4ccfc34880e857c9e3</originalsourceid><addsrcrecordid>eNqVkNFq2zAUhsVY6bJ0jzDwVdkunB1JtixlpVDcbi2UhZZc9KJwUOSTxp1sp1ZMydvXJlmhuxjsSki__u8cPsbOOUw4gPjGwWQx8ER84cYA5zz9qtSUw4kAk06nZ1fncf4rvxVagFJ9w5zKCUzy2XcR37xjo9f6ezYCAB2nibz7wD6G8NhfM5HKQ3YohEgyJUcsn1PYlK7zto1a8nYdKCrryK1KX7RUR8_lZhVZ120oqpvab6v1qll4O3QiT91vqkp7xA6W1gf6tD_HbP7jYp5fxtezn1f52XXspM5MbKHQwqYOUpOQI73UiXRWFYlacKsBlFwoZwqXkdT9q3NLJxOtgXSaOUNyzI532HXbPHX92liVwZH3tqamCzggTNpDx-x-99G1TQgtLXHdlpVtt8gBB8U4OMLBEf5RjEoN6aAYsVeMbxWjRMB8hgJvevzn_R7doqLiFb532ucPu_y59LT9z9n_HP1XIl8AZz2aDg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80069584</pqid></control><display><type>article</type><title>Testicular relapse in children with acute nonlymphoblastic leukemia</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Furman, Wayne L. ; Fontanesi, James ; Hustu, Omar ; Dahl, Gary V. ; Kalwinsky, David K. ; Pui, Ching‐Hon</creator><creatorcontrib>Furman, Wayne L. ; Fontanesi, James ; Hustu, Omar ; Dahl, Gary V. ; Kalwinsky, David K. ; Pui, Ching‐Hon</creatorcontrib><description>The clinical course and other distinctive features of five children who developed a testicular relapse 4 months to 25 months after the diagnosis of acute nonlymphoblastic leukemia (ANLL) are described. the chief presenting feature at relapse was painless testicular enlargement, as is also seen in children with acute lymphoblastic leukemia who relapse in the testes. By French–American–British convention, the malignant cells were classified as M4 (myelomonoblastic) in four cases and M2 (myeloblastic) in one. All children received a course of multiagent reinduction chemotherapy and all but one received local irradiation to the testes. Only one of these children, whose relapse was a late event after elective cessation of therapy, is a long‐term survivor. A comparison with six previously published cases shows similar clinical characteristics and outcome. Given the poor responses of such patients to conventional treatment, it seems worthwhile to consider the use of intensive reinduction chemotherapy with concomitant bilateral testicular irradiation followed by remission intensification and an autologous or allogenic marrow transplant.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19901115)66:10&lt;2095::AID-CNCR2820661009&gt;3.0.CO;2-Q</identifier><identifier>PMID: 2224763</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adolescent ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Child ; Humans ; Infant ; Leukemia, Myeloid, Acute - blood ; Leukemia, Myeloid, Acute - drug therapy ; Leukocyte Count ; Male ; Testicular Neoplasms - blood ; Testicular Neoplasms - drug therapy</subject><ispartof>Cancer, 1990-11, Vol.66 (10), p.2095-2098</ispartof><rights>Copyright © 1990 American Cancer Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3879-a0d82a5c0594ece8f843ca6d46b1a80063b6c9dc7e386d4ccfc34880e857c9e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2224763$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Furman, Wayne L.</creatorcontrib><creatorcontrib>Fontanesi, James</creatorcontrib><creatorcontrib>Hustu, Omar</creatorcontrib><creatorcontrib>Dahl, Gary V.</creatorcontrib><creatorcontrib>Kalwinsky, David K.</creatorcontrib><creatorcontrib>Pui, Ching‐Hon</creatorcontrib><title>Testicular relapse in children with acute nonlymphoblastic leukemia</title><title>Cancer</title><addtitle>Cancer</addtitle><description>The clinical course and other distinctive features of five children who developed a testicular relapse 4 months to 25 months after the diagnosis of acute nonlymphoblastic leukemia (ANLL) are described. the chief presenting feature at relapse was painless testicular enlargement, as is also seen in children with acute lymphoblastic leukemia who relapse in the testes. By French–American–British convention, the malignant cells were classified as M4 (myelomonoblastic) in four cases and M2 (myeloblastic) in one. All children received a course of multiagent reinduction chemotherapy and all but one received local irradiation to the testes. Only one of these children, whose relapse was a late event after elective cessation of therapy, is a long‐term survivor. A comparison with six previously published cases shows similar clinical characteristics and outcome. Given the poor responses of such patients to conventional treatment, it seems worthwhile to consider the use of intensive reinduction chemotherapy with concomitant bilateral testicular irradiation followed by remission intensification and an autologous or allogenic marrow transplant.</description><subject>Adolescent</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Child</subject><subject>Humans</subject><subject>Infant</subject><subject>Leukemia, Myeloid, Acute - blood</subject><subject>Leukemia, Myeloid, Acute - drug therapy</subject><subject>Leukocyte Count</subject><subject>Male</subject><subject>Testicular Neoplasms - blood</subject><subject>Testicular Neoplasms - drug therapy</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkNFq2zAUhsVY6bJ0jzDwVdkunB1JtixlpVDcbi2UhZZc9KJwUOSTxp1sp1ZMydvXJlmhuxjsSki__u8cPsbOOUw4gPjGwWQx8ER84cYA5zz9qtSUw4kAk06nZ1fncf4rvxVagFJ9w5zKCUzy2XcR37xjo9f6ezYCAB2nibz7wD6G8NhfM5HKQ3YohEgyJUcsn1PYlK7zto1a8nYdKCrryK1KX7RUR8_lZhVZ120oqpvab6v1qll4O3QiT91vqkp7xA6W1gf6tD_HbP7jYp5fxtezn1f52XXspM5MbKHQwqYOUpOQI73UiXRWFYlacKsBlFwoZwqXkdT9q3NLJxOtgXSaOUNyzI532HXbPHX92liVwZH3tqamCzggTNpDx-x-99G1TQgtLXHdlpVtt8gBB8U4OMLBEf5RjEoN6aAYsVeMbxWjRMB8hgJvevzn_R7doqLiFb532ucPu_y59LT9z9n_HP1XIl8AZz2aDg</recordid><startdate>19901115</startdate><enddate>19901115</enddate><creator>Furman, Wayne L.</creator><creator>Fontanesi, James</creator><creator>Hustu, Omar</creator><creator>Dahl, Gary V.</creator><creator>Kalwinsky, David K.</creator><creator>Pui, Ching‐Hon</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19901115</creationdate><title>Testicular relapse in children with acute nonlymphoblastic leukemia</title><author>Furman, Wayne L. ; Fontanesi, James ; Hustu, Omar ; Dahl, Gary V. ; Kalwinsky, David K. ; Pui, Ching‐Hon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3879-a0d82a5c0594ece8f843ca6d46b1a80063b6c9dc7e386d4ccfc34880e857c9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adolescent</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Child</topic><topic>Humans</topic><topic>Infant</topic><topic>Leukemia, Myeloid, Acute - blood</topic><topic>Leukemia, Myeloid, Acute - drug therapy</topic><topic>Leukocyte Count</topic><topic>Male</topic><topic>Testicular Neoplasms - blood</topic><topic>Testicular Neoplasms - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Furman, Wayne L.</creatorcontrib><creatorcontrib>Fontanesi, James</creatorcontrib><creatorcontrib>Hustu, Omar</creatorcontrib><creatorcontrib>Dahl, Gary V.</creatorcontrib><creatorcontrib>Kalwinsky, David K.</creatorcontrib><creatorcontrib>Pui, Ching‐Hon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Furman, Wayne L.</au><au>Fontanesi, James</au><au>Hustu, Omar</au><au>Dahl, Gary V.</au><au>Kalwinsky, David K.</au><au>Pui, Ching‐Hon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Testicular relapse in children with acute nonlymphoblastic leukemia</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1990-11-15</date><risdate>1990</risdate><volume>66</volume><issue>10</issue><spage>2095</spage><epage>2098</epage><pages>2095-2098</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>The clinical course and other distinctive features of five children who developed a testicular relapse 4 months to 25 months after the diagnosis of acute nonlymphoblastic leukemia (ANLL) are described. the chief presenting feature at relapse was painless testicular enlargement, as is also seen in children with acute lymphoblastic leukemia who relapse in the testes. By French–American–British convention, the malignant cells were classified as M4 (myelomonoblastic) in four cases and M2 (myeloblastic) in one. All children received a course of multiagent reinduction chemotherapy and all but one received local irradiation to the testes. Only one of these children, whose relapse was a late event after elective cessation of therapy, is a long‐term survivor. A comparison with six previously published cases shows similar clinical characteristics and outcome. Given the poor responses of such patients to conventional treatment, it seems worthwhile to consider the use of intensive reinduction chemotherapy with concomitant bilateral testicular irradiation followed by remission intensification and an autologous or allogenic marrow transplant.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>2224763</pmid><doi>10.1002/1097-0142(19901115)66:10&lt;2095::AID-CNCR2820661009&gt;3.0.CO;2-Q</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1990-11, Vol.66 (10), p.2095-2098
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_80069584
source MEDLINE; Alma/SFX Local Collection
subjects Adolescent
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Child
Humans
Infant
Leukemia, Myeloid, Acute - blood
Leukemia, Myeloid, Acute - drug therapy
Leukocyte Count
Male
Testicular Neoplasms - blood
Testicular Neoplasms - drug therapy
title Testicular relapse in children with acute nonlymphoblastic leukemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A41%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Testicular%20relapse%20in%20children%20with%20acute%20nonlymphoblastic%20leukemia&rft.jtitle=Cancer&rft.au=Furman,%20Wayne%20L.&rft.date=1990-11-15&rft.volume=66&rft.issue=10&rft.spage=2095&rft.epage=2098&rft.pages=2095-2098&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(19901115)66:10%3C2095::AID-CNCR2820661009%3E3.0.CO;2-Q&rft_dat=%3Cproquest_cross%3E80069584%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80069584&rft_id=info:pmid/2224763&rfr_iscdi=true